National Institutes of Health (NIH)
Bethesda
MD
United States
282 articles with National Institutes of Health (NIH)
-
Vivera Partners with NINDS of NIH to Identify Potential Stuttering Treatments
5/17/2022
Vivera Biosciences is pleased to announce its collaborative progress on a Cooperative Research and Development Agreement with the National Institute of Neurological Disorders and Stroke, an Institute within the National Institutes of Health that aims to foster and advance cutting-edge neuroscience research to reduce the burden of neurological disease.
-
With regulatory approvals beginning to break through, attendees at ISCT's annual meeting set out along the translational pathway. Organizers shared their findings with BioSpace.
-
NIH Program Study Finds Rising Levels Of Chemical Exposures In Pregnant Women
5/11/2022
A new National Institutes of Health -funded study found that pregnant women had been exposed to rising levels of certain chemicals, especially replacement chemicals: chemicals meant to replace other chemicals that have been banned or phased out.
-
Moderna is still fending off patent challenges over the lipid nanoparticle delivery system used in its COVID-19 vaccine.
-
National Institute of Health (NIH) awards Aracari Biosciences a grant to further develop proprietary human bone marrow technology that models in vivo drug responses
5/5/2022
Aracari Biosciences, Inc. announces a grant award from the National Institute of Health to further develop Aracari's proprietary human bone marrow technology that models in vivo drug responses.
-
Chemical Insights Research Institute Receives Prestigious Award from the National Institutes of Health
5/5/2022
In 2020, 3.7% of U.S. adults currently used electronic nicotine delivery systems 1 with 18.5% of users reporting gingival pain and or oral bleeding2 making this a concerning human health threat.
-
Albert Einstein College of Medicine Receives $4.2 Million NIH Grant to Discover Novel Markers of Early Alzheimer's Disease
4/26/2022
Diagnosing Alzheimer's disease can be a complex and time-consuming process, requiring evaluations ranging from brain scans to cognitive and lab tests to reviews of medical history and symptoms.
-
Although treating patients is the top priority of the biopharma industry, there’s no doubt that money is the driver. This is a broad look at the current state of biopharma bucks.
-
More than two years into the COVID-19 pandemic, some experts, business leaders and government agencies are starting to prep for the next potential pandemic.
-
There are an estimated 2.3 million people living with Multiple Sclerosis and hundreds of thousands more undiagnosed, adding up to an annual cost of nearly $85 billion for care in the United States.
-
The FDA is looking at revising the current vaccine strategy and emphasizing that individuals need to consider their own risk tolerance. For that and more, continue reading.
-
Texas Biomed selected as premier national tuberculosis research center
3/29/2022
Texas Biomedical Research Institute has been selected by the National Institutes of Health to host one of the nation's inaugural training centers for tuberculosis research.
-
Dascena Awarded NIH Grant to Better Predict the Onset of Sepsis in Patients
3/29/2022
Company will use HindSight grant to conduct a clinical study that seeks to reduce alert fatigue Dascena has received a grant from the National Institute of Health to conduct a clinical study that evaluates the efficacy of its HindSight algorithm to accurately and efficiently predict the onset of sepsis in patients.
-
Thermo Fisher Scientific to Support National Program to Accelerate SARS-CoV-2 Variant Identification
3/23/2022
Thermo Fisher Scientific Inc., the world leader in serving science, today announced its collaboration with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative, Helix, and Rosalind aimed at developing a new genotyping method for SARS-CoV-2 that could speed up the identification of variants as they emerge.
-
New Medical Imaging Center for Translational Cancer Research Announced at The University of Oklahoma
3/22/2022
The University of Oklahoma has received funding from the National Institutes of Health to establish the Oklahoma Center of Medical Imaging for Translational Cancer Research.
-
BrainStorm Cell Therapeutics’ NurOwn has taken the amyotrophic lateral sclerosis (ALS) community by storm with new genetic data from its Phase III trial.
-
Moderna announced that the first participant has been dosed in a Phase I trial of its HIV trimer mRNA vaccine, mRNA-1574.
-
Venatorx Pharmaceuticals shared that its Phase III trial on the investigational treatment for complicated urinary tract infections in adults delivered positive outcomes.
-
APOE4 is associated with an increased risk of Alzheimer’s disease. A European consortium coordinated by the University of Geneva believes they have identified at least one mechanism of action.
-
SAB Biotherapeutics Reports NIH is Discontinuing Phase 3 ACTIV-2 Trial Assessing SAB-185 for Treatment of COVID-19 Due to Declining COVID Hospitalizations
3/2/2022
SAB Biotherapeutics reported that due to low hospitalization and death rates in the trial, the National Institutes of Health’s ACTIV-2 Program is discontinuing enrollment in its Phase 3 COVID-19 trial.